asrm_logo_color_tagline.png
Menu

COVID-19 Press Releases and Announcements

ASRM Issues New Guidance on Fertility Care During COVID-19 Pandemic: Calls for Suspension of Most Treatments

The American Society for Reproductive Medicine (ASRM), the global leader in reproductive medicine, today issues new guidance for its members as they manage patients in the midst of the COVID-19 pandemic.  Developed by an expert Task Force, of physicians, embryologists, and mental health professionals, the new document recommends suspension of new, non-urgent treatments.

ASRM Announces Creation Of COVID-19 Task Force

A new strain of corona virus emerged in China in late 2019, producing a respiratory infection, that can severe consequences, including death, especially in the older population. COVID-19, as the disease is now known, has been declared a global pandemic by the World Health Organization. There have been over 100,000 cases throughout the world and the WHO expects the virus to emerge in every country.

SART and ASRM Issue Advice for Infertility Patients Concerning the Novel Coronavirus (COVID-19)

Patients, including prospective oocyte and sperm donors, as well as gestational carriers, who meet the diagnostic criteria for COVID-19 infection should avoid becoming pregnant. If they are undergoing active infertility treatment, we suggest that these patients consider freezing all oocytes or embryos and avoiding an embryo transfer until they are disease-free.

FDA Message on Coronavirus

The FDA continues to work closely with CDC and other federal and international agencies to monitor the evolving outbreak of the 2019 novel coronavirus (COVID-19) that was first identified in Wuhan, Hubei Province, China.

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew